Table 1.

Patients’ characteristics (n = 110).

Characteristics		Number	(%)
Age at diagnosis (years)	Median	39
	Range	25–66
Hormonal status	ER-positive	81	73.6
	PR-positive	85	77.3
HER-2 status	HER2-positive	21	19.1
	HER2-negative	86	78.2
	Unknown	3	2.7
Triple negative		13	11.8
Disease stage	Early stage	103	93.6
	Metastatic	7	6.4

ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.